"The liver actually starts looking substantially better under the microscope in these patients," noted Sanyal. The researchers also found that 36.8% of the semaglutide group saw improvements in ...

Semaglutide effectively treats liver disease in two thirds of patients, new research has found. Results from the ESSENCE phase 3 clinical trial published today in the New England Journal of ...

and inconvenience for many patients. Sublingual administration offers a potential alternative to both the approved injectable semaglutide (Ozempic and Wegovy) and the oral form (Rybelsus ...